drugset / Trial / NCT02373462

Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)

NCT02373462 ↗

Phase 4 Terminated 1 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

To study the effect of olmesartan on walking distance and quality of life in peripheral artery disease patients with hypertension treated For intermittent claudication.

Timeline

Start
2015-08-25
Primary completion
2015-11-17
Completion
2015-11-17

Outcome

Outcome not reported

Stopped: “The data of the paper referenced in the preparation of the protocols in this task were manipulated and the paper was withdrawn.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Olmesartan Other / unclassified 40 mg —